MELISSA SIMMONS: Open Payments
NPI 1467100875 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 30 payments from 6 companies in 2025. Trend: 2023 $922 · 2024 $469 · 2025 $663
Food & beverage: $633Education: $30
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $405 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $180 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Neos Therapeutics, LP | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, REJOYN, EXXUA, ARISTADA.
Industry payments across IN — which companies pay providers there.
